Drug Resistance: The Role of Sphingolipid Metabolism
International Journal of Molecular Sciences · 15.04.2025 · 26 (8) · 3716
DOI: 10.3390/ijms26083716 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.04.2025. Verfasst von Assem Zhakupova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Nazarbayev University School of Medicine, Astana 010000, Kazakhstan. Hauptthemen laut MEDLINE: Sphingolipids, Drug Resistance, Neoplasm, Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Committee of Ministry of Science and Higher Education of Kazakhstan, Nazarbayev University Collaborative Research Grant.
Abstract (Originalsprache)
A significant challenge in cancer treatment is the rising problem of drug resistance that reduces the effectiveness of therapeutic strategies. Current knowledge shows that multiple mechanisms play a role in cancer drug resistance. Another mechanism that has gained attention is the alteration in sphingolipid trafficking and the dysregulation of its metabolism, which was reported to cause cancer-associated drug resistance. Sphingolipids are lipids containing sphingosine and have multiple roles, ranging from lipid raft formation, apoptosis, and cell signaling to immune cell trafficking. Recent studies show that in developing cancer cells, altered or dysregulated sphingolipids are associated with drug efflux and promote the survival of cancer cells by bypassing apoptosis. Upregulated levels of the glucosylceramide synthase (GCS), an enzyme that functions in sphingolipid metabolism, lead to the upregulated ABCB1 gene that induces drug efflux from the cancer cells. These bypass mechanisms make drugs that induce apoptosis in tumor cells ineffective. By highlighting the current findings, this review aims to provide a mechanism of drug resistance caused by the dysregulation of glucosylceramide synthase, sphingosine kinase, and acid ceramidase enzymes as possible therapeutic targets to enhance the effectiveness of the currently used chemotherapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Nazarbayev University School of Medicine, Astana 010000, Kazakhstan.
- Drug Discovery and Development Laboratory, National Laboratory Astana, Astana 010000, Kazakhstan.
- LLP "VICTUS PHARM", Astana 010000, Kazakhstan.
ORCID-Profile: Assem Zhakupova, Shynggys Sergazy
Förderung
- Science Committee of Ministry of Science and Higher Education of Kazakhstan
- Nazarbayev University Collaborative Research Grant
Zitieren
APA
Zhakupova, A., Zeinolla, A., Kokabi, K., Sergazy, S., & Aljofan, M. (2025). Drug Resistance: The Role of Sphingolipid Metabolism. International Journal of Molecular Sciences, 26(8), 3716. https://doi.org/10.3390/ijms26083716
Vancouver
Zhakupova A, Zeinolla A, Kokabi K, Sergazy S, Aljofan M. Drug Resistance: The Role of Sphingolipid Metabolism. International Journal of Molecular Sciences. 2025;26(8):3716. doi:10.3390/ijms26083716
BibTeX
@article{Zhakupova2025,
author = {Zhakupova, Assem and Zeinolla, Adelina and Kokabi, Kamilya and Sergazy, Shynggys and Aljofan, Mohamad},
title = {Drug Resistance: The Role of Sphingolipid Metabolism},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {8},
pages = {3716},
doi = {10.3390/ijms26083716}
}
EUVIMED